Central Blood Bank parent in merger talks with Florida system
The corporate parent of the Central Blood Bank is in talks with a Florida-based blood center about a merger that would establish the largest independent nonprofit blood management system in the nation.
A blood center combining the Institute for Transfusion Medicine Inc., based in Green Tree, and OneBlood Inc., of Orlando, Fla., would distribute nearly 2 million units annually with combined revenue of $480 million and more than 3,500 employees.
The two centers said in a statement that the talks and a financial review are expected to last for several months, during which they will continue operations with no changes in service.
A possible merger occurs as advances in medical technology have made the need for blood less frequent. From 2008 to 2011, demand dropped by 8.2 percent, according to a report last year from the American Association of Blood Banks, which expects the decline to continue. Blood banks are changing to collection on an as-needed basis, medical officials said.
“We have entered a new era of blood banking. Hospital consolidation continues to occur, and medical facilities need larger-scale blood centers to serve multiple locations in broader service regions,” said Jim Covert, CEO of the Institute for Transfusion Medicine in the statement.
“We must do our part to help ensure the blood is available when and where it is needed while assisting the industry in its efforts to control health care costs,” Covert said. He could not be reached for further comment.
The American Red Cross, a charitable organization, is the largest supplier of blood and blood products in the United States, collecting and processing more than 40 percent of the blood supply and distributing it to 3,000 hospitals and centers nationwide. The largest independent nonprofit blood center is BloodSystems Inc. of Scottsdale, Ariz., followed by OneBlood, New York Blood Centers and the Institute for Transfusion Medicine, said Susan Forbes, a spokeswoman for OneBlood.
Forbes said it's too early to say what the effect of a merger would have on employees of the two companies or their organizational structure. But there is no overlap in service areas, she said. It is too early to say which executives would lead a combined company, she said.
The Institute for Transfusion Medicine operates in the Pittsburgh area as the Central Blood Bank and in Chicago, Virginia and parts of Ohio and West Virginia. The institute was established in 1987 and later acquired other blood centers. It distributes about 671,000 units of blood products annually, employs 1,100 and operates 43 donor centers.
OneBlood serves most of Florida and parts of South Georgia and Alabama. It was formed in 2012 when three of Florida's blood centers merged. OneBlood distributes nearly 1.3 million units annually, employs 2,000, operates 70 donor centers.
“By combining the resources of two industry-leading blood centers we can further strengthen the blood supply, especially in times of natural disasters such as hurricanes in the south and winter storms in the north, while at the same time create operational efficiencies that bring additional value to our healthcare partners and our blood donors,” said Don Doddridge, CEO of OneBlood.
John D. Oravecz is a staff writer for Trib Total Media. He can be reached at 412-320-7882 or email@example.com.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- Faulty air bags in 30M vehicles
- Bond mutual funds continue to carry their weight
- Amazon investors’ patience wears thin
- Mini goes mainstream
- Toyota Yaris adds French flair for ’15
- Motoring Q&A: ‘Check engine’ light doesn’t reset itself
- Sell-off reins in complacency
- Calgon Carbon poised for explosive growth
- PPG Industries to buy Westmoreland Supply paint store chain
- High pollution levels found near Ohio gas wells
- Plastics, tech sectors crucial to cracker plants